National Policy on Bio-Manufacturing: India’s Strategic Shift Toward a Circular Bio-Economy
GS3
The Union Cabinet has approved the National Policy on Bio-Manufacturing to promote sustainable production of bio-based chemicals, plastics, and pharmaceuticals. This initiative aims to reduce import dependency and foster a robust startup ecosystem under the Bio-E3 framework.
The Union Cabinet’s approval of the National Policy on Bio-Manufacturing marks a transformative step in India’s industrial and environmental strategy. Rooted in the 'Bio-E3' (Biotechnology for Economy, Environment, and Employment) framework, the policy seeks to transition India from traditional fossil-fuel-based manufacturing to high-performance, bio-based manufacturing.
The policy focuses on six thematic areas: bio-based chemicals and enzymes, functional foods and smart proteins, precision biotherapeutics, climate-resilient agriculture, carbon capture and utilization, and futuristic marine and space research. By incentivizing the production of bio-plastics and bio-pharmaceuticals, the government aims to address the critical challenge of import dependency, particularly in the pharmaceutical sector where India relies heavily on external sources for Active Pharmaceutical Ingredients (APIs).
Continue reading — free with login
JeetoBharat publishes daily UPSC current affairs mapped to the Mains syllabus. Log in to read full articles.
Log in to read full articleNo credit card required. Free registered users get unlimited access.
This article was curated using AI. While we strive for accuracy, please verify critical facts from official sources.